The FDA said the guidance is applicable to machine learning-enabled device software functions that device manufacturers plan to modify over time.
Some of its recommendations include making sure AI and machine learning devices consider race, ethnicity, disease severity, gender, age and geography of data sets.
The FDA seeks feedback on the draft guidance by July 3. Read the full guidance here.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
